HEADER METAL BINDING PROTEIN 09-JAN-07 2OH3 TITLE CRYSTAL STRUCTURE OF COG1633: UNCHARACTERIZED CONSERVED PROTEIN TITLE 2 (ZP_00055496.1) FROM MAGNETOSPIRILLUM MAGNETOTACTICUM MS-1 AT 2.00 A TITLE 3 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: COG1633: UNCHARACTERIZED CONSERVED PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: RUBRERYTHRIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MAGNETOSPIRILLUM MAGNETOTACTICUM; SOURCE 3 ORGANISM_TAXID: 272627; SOURCE 4 STRAIN: MS-1; SOURCE 5 GENE: ZP_00055496.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS RUBRERYTHRIN, ZP_00055496.1, COG1633: UNCHARACTERIZED CONSERVED KEYWDS 2 PROTEIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, KEYWDS 3 JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-2, METAL BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 27-DEC-23 2OH3 1 REMARK LINK REVDAT 4 18-OCT-17 2OH3 1 REMARK REVDAT 3 13-JUL-11 2OH3 1 VERSN REVDAT 2 24-FEB-09 2OH3 1 VERSN REVDAT 1 23-JAN-07 2OH3 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF COG1633: UNCHARACTERIZED CONSERVED JRNL TITL 2 PROTEIN (ZP_00055496.1) FROM MAGNETOSPIRILLUM JRNL TITL 3 MAGNETOTACTICUM MS-1 AT 2.00 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 14778 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 744 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1005 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.2400 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1178 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 37.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.24000 REMARK 3 B22 (A**2) : -0.27000 REMARK 3 B33 (A**2) : 2.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.156 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.150 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.111 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.432 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1274 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1137 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1727 ; 1.491 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2644 ; 0.909 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 163 ; 5.156 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 63 ;39.194 ;23.968 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 211 ;14.201 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;22.839 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 181 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1428 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 264 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 290 ; 0.225 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1085 ; 0.193 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 601 ; 0.185 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 720 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 76 ; 0.182 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 3 ; 0.092 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 12 ; 0.283 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 67 ; 0.344 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.141 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 786 ; 0.904 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 305 ; 0.236 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1227 ; 1.479 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 555 ; 2.434 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 492 ; 3.785 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 153 REMARK 3 ORIGIN FOR THE GROUP (A): 31.0082 24.5530 13.7822 REMARK 3 T TENSOR REMARK 3 T11: -0.1218 T22: -0.1607 REMARK 3 T33: -0.1768 T12: -0.0219 REMARK 3 T13: -0.0042 T23: 0.0345 REMARK 3 L TENSOR REMARK 3 L11: 5.1804 L22: 1.7399 REMARK 3 L33: 1.6280 L12: -0.7722 REMARK 3 L13: 1.1000 L23: -0.3541 REMARK 3 S TENSOR REMARK 3 S11: -0.0297 S12: 0.2462 S13: 0.2082 REMARK 3 S21: -0.1320 S22: 0.0244 S23: 0.0003 REMARK 3 S31: 0.0029 S32: 0.0489 S33: 0.0053 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 4. THE RESIDUES 1-2, 85-87, AND 155-166 ARE DISORDERED AND WERE REMARK 3 NOT BUILT DUE TO INSUFFICIENT ELECTRON DENSITY. 5. THE PRESENCE REMARK 3 OF ZINC IS SUPPORTED WITH X-RAY FLOURESCENCE AND ANOMALOUS REMARK 3 DIFFERENCE FOURIER MAPS. 6. IMIDAZOLE AND PEG WERE MODELED BASED REMARK 3 ON CRYSTALLIZATION AND PURIFICATION CONDITIONS. REMARK 4 REMARK 4 2OH3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041127. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.10 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97913 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14778 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 28.105 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.03500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.2M NAF, 20.0% PEG-3350, PH REMARK 280 7.1, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K, PH 7.10 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 32.18000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.64000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 44.89500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 32.18000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.64000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 44.89500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 32.18000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 37.64000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 44.89500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 32.18000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 37.64000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 44.89500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 AUTHORS STATE THAT STATIC LIGHT SCATTERING WITH ANALYTICAL REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY MEASUREMENTS INDICATE THAT REMARK 300 THE DIMER IS A BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION REMARK 300 STATE IN SOLUTION REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 64.36000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 75.28000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 GLY A 2 REMARK 465 ASN A 85 REMARK 465 ASP A 86 REMARK 465 ILE A 87 REMARK 465 TRP A 155 REMARK 465 SER A 156 REMARK 465 GLU A 157 REMARK 465 ASP A 158 REMARK 465 ALA A 159 REMARK 465 ASP A 160 REMARK 465 PRO A 161 REMARK 465 ALA A 162 REMARK 465 GLN A 163 REMARK 465 CYS A 164 REMARK 465 VAL A 165 REMARK 465 ASP A 166 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 3 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 61 CZ NH1 NH2 REMARK 470 LYS A 67 CE NZ REMARK 470 GLU A 80 CG CD OE1 OE2 REMARK 470 VAL A 81 CB CG1 CG2 REMARK 470 ASP A 83 CG OD1 OD2 REMARK 470 MSE A 91 SE CE REMARK 470 ARG A 106 CZ NH1 NH2 REMARK 470 SER A 152 OG REMARK 470 ILE A 153 CG1 CG2 CD1 REMARK 470 THR A 154 CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MSE A 45 SE MSE A 45 CE -0.409 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 73 -23.05 -144.36 REMARK 500 GLU A 80 75.79 -100.32 REMARK 500 ASP A 83 -8.34 93.41 REMARK 500 ILE A 153 -179.27 -64.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 300 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 104 OE1 REMARK 620 2 GLU A 104 OE2 51.5 REMARK 620 3 GLU A 134 OE1 92.3 132.8 REMARK 620 4 HIS A 137 ND1 109.5 109.2 111.6 REMARK 620 5 IMD A 301 N1 121.7 73.5 116.4 105.0 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 370399 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 (1) THE CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL REMARK 999 PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMARK 999 REMOVED WITH TEV PROTEASE, LEAVING ONLY A GLYCINE (0), REMARK 999 FOLLOWED BY THE TARGET SEQUENCE. REMARK 999 (2) THE SEQUENCE OF THIS PROTEIN WAS NOT AVAILABLE REMARK 999 AT THE UNIPROT DATABASE AT THE TIME OF DEPOSITION. REMARK 999 (3) THE SEQUENCE IS AVAILABLE FROM GENBANK UNDER REMARK 999 ACCESSION ID ZP_00055496.1 AND FROM THE UNIPROT REMARK 999 ARCHIVE UNDER ACCESSION ID UPI00003846C6 DBREF 2OH3 A 0 166 PDB 2OH3 2OH3 0 166 SEQRES 1 A 167 GLY MSE GLY TYR THR LEU ALA GLU PHE LEU ALA HIS ALA SEQRES 2 A 167 ILE ALA LEU GLU THR GLU ALA ALA GLU ARG TYR VAL GLU SEQRES 3 A 167 LEU ALA ASP MSE MSE GLU ALA HIS ASN ASN LEU ASP THR SEQRES 4 A 167 ALA THR VAL PHE ARG ASP MSE ALA ARG PHE SER THR LEU SEQRES 5 A 167 HIS GLY ASP GLU ILE LYS GLN ARG SER ARG ALA LEU GLU SEQRES 6 A 167 LEU PRO LYS LEU MSE SER TRP GLN TYR ARG TRP LYS THR SEQRES 7 A 167 PRO PRO GLU VAL GLY ASP GLU ASN ASP ILE HIS TYR LEU SEQRES 8 A 167 MSE THR PRO TYR HIS ALA LEU ARG TYR ALA ARG ASP ASN SEQRES 9 A 167 GLU ILE ARG GLY MSE GLU TYR TYR LYS GLU ALA ALA ALA SEQRES 10 A 167 ASN SER ALA ASP PRO GLU VAL LYS ARG LEU GLY ALA ASP SEQRES 11 A 167 PHE ALA ALA GLU GLU ALA GLU HIS VAL VAL ALA LEU ASP SEQRES 12 A 167 LYS TRP ILE GLU LYS THR PRO ARG PRO SER ILE THR TRP SEQRES 13 A 167 SER GLU ASP ALA ASP PRO ALA GLN CYS VAL ASP MODRES 2OH3 MSE A 29 MET SELENOMETHIONINE MODRES 2OH3 MSE A 30 MET SELENOMETHIONINE MODRES 2OH3 MSE A 45 MET SELENOMETHIONINE MODRES 2OH3 MSE A 69 MET SELENOMETHIONINE MODRES 2OH3 MSE A 91 MET SELENOMETHIONINE MODRES 2OH3 MSE A 108 MET SELENOMETHIONINE HET MSE A 29 13 HET MSE A 30 8 HET MSE A 45 8 HET MSE A 69 13 HET MSE A 91 6 HET MSE A 108 8 HET ZN A 300 1 HET IMD A 301 5 HET PGE A 302 10 HET PGE A 303 10 HETNAM MSE SELENOMETHIONINE HETNAM ZN ZINC ION HETNAM IMD IMIDAZOLE HETNAM PGE TRIETHYLENE GLYCOL FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 2 ZN ZN 2+ FORMUL 3 IMD C3 H5 N2 1+ FORMUL 4 PGE 2(C6 H14 O4) FORMUL 6 HOH *111(H2 O) HELIX 1 1 THR A 4 HIS A 33 1 30 HELIX 2 2 ASN A 35 ARG A 61 1 27 HELIX 3 3 MSE A 69 TYR A 73 5 5 HELIX 4 4 HIS A 88 MSE A 91 5 4 HELIX 5 5 THR A 92 SER A 118 1 27 HELIX 6 6 ASP A 120 THR A 148 1 29 LINK C ASP A 28 N MSE A 29 1555 1555 1.33 LINK C MSE A 29 N MSE A 30 1555 1555 1.33 LINK C MSE A 30 N GLU A 31 1555 1555 1.33 LINK C ASP A 44 N MSE A 45 1555 1555 1.32 LINK C MSE A 45 N ALA A 46 1555 1555 1.33 LINK C LEU A 68 N MSE A 69 1555 1555 1.33 LINK C MSE A 69 N SER A 70 1555 1555 1.33 LINK C LEU A 90 N MSE A 91 1555 1555 1.33 LINK C MSE A 91 N THR A 92 1555 1555 1.33 LINK C GLY A 107 N MSE A 108 1555 1555 1.34 LINK C MSE A 108 N GLU A 109 1555 1555 1.33 LINK OE1 GLU A 104 ZN ZN A 300 1555 1555 1.99 LINK OE2 GLU A 104 ZN ZN A 300 1555 1555 2.76 LINK OE1 GLU A 134 ZN ZN A 300 1555 1555 1.87 LINK ND1 HIS A 137 ZN ZN A 300 1555 1555 2.06 LINK ZN ZN A 300 N1 IMD A 301 1555 1555 2.02 CISPEP 1 VAL A 81 GLY A 82 0 -10.66 SITE 1 AC1 5 MSE A 45 GLU A 104 GLU A 134 HIS A 137 SITE 2 AC1 5 IMD A 301 SITE 1 AC2 10 GLU A 16 ALA A 19 TYR A 23 MSE A 45 SITE 2 AC2 10 PHE A 48 SER A 49 GLU A 104 GLU A 134 SITE 3 AC2 10 HIS A 137 ZN A 300 SITE 1 AC3 2 LYS A 112 ALA A 131 SITE 1 AC4 4 ILE A 105 ALA A 135 VAL A 138 VAL A 139 CRYST1 64.360 75.280 89.790 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015540 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013280 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011140 0.00000